Restrictive Cardiomyopathy

Treatment

Treatment includes therapies specific to the underlying condition causing the restrictive cardiomyopathy.

Treatment for symptoms of heart failure in restrictive cardiomyopathy includes diuretics to help reduce the congestion. Other medications traditionally used in heart failure may not benefit restrictive cardiomyopathy. The patient should also limit their sodium (salt) intake.

If atrial fibrillation is present, patients should be on blood thinning medications to prevent strokes, and patients may be considered for therapies to keep their hearts in a normal rhythm.

Improving Patient Care

The Society for Cardiovascular Angiography & Interventions (SCAI) is the leading nonprofit medical society representing invasive and interventional cardiology. Founded in 1978, SCAI’s mission is to lead the global interventional cardiovascular community through education, advocacy, research, and quality patient care. 

SCAI has dedicated its work to advancing the profession and is the designated society for guidance, representation, professional recognition, education, and research opportunities for invasive and interventional cardiology professionals. For more than 40 years, SCAI has personified professional excellence and innovation globally, fostering a trusted community of more than 4,500 members dedicated to medical advancement and lifesaving care for adults and children with cardiovascular disease.  

Society for Cardiovascular Angiography & Interventions®

1100 17th Street NW, Suite 400, Washington, DC 20036